SUMMARY Clinical studies suggest that steatorrhoea can be associated with excessive absorption of dietary oxalate. We examined the influence of bile salts, Ca++, and long-chain fatty acid on the absorption of oxalate and water by rat intestine in vivo. Absorption was measured under steady-state conditions during single-pass infusions. Each intestinal segment served as its own control.
excessive absorption of dietary oxalate. Changes in the luminal milieu of the intestine, then, and not alterations in absorptive cells seem to lead to enhanced oxalate absorption.
Little is known about intestinal oxalate absorption under normal conditions. Binder has described an energy-independent, unsaturable process for oxalate transport, which was demonstrable in everted sacs of rat duodenum, jejunum, ileum, and colon (Binder, 1974) . The concentration of luminal oxalate, therefore, is a determinant of the rate of oxalate absorption. What factors control the concentration of luminal oxalate? Calcium depresses the solubility of oxalate in vitro; long-chain fatty acid forms insoluble salts with calcium, thereby improving the solubility of oxalate in such a mixture (Binder, 1974) . We examined the effects of bile salts, calcium, and fatty acid on oxalate absorption in rat intestine in vivo in the hope of elucidating the pathogenesis of enteric hyperoxaluria.
Methods

MATERIALS
Taurocholate was synthesized according to Norman 543 (Norman, 1955) . The product contained a trace of taurine: its [UX]D23 was 219 (c = 5 in water); reported, 21-7 ± 0 3 (Norman, 1955) .
Linoleic acid, 99 % pure, a product of the Hormel Institute, was pure as determined by thin-layer chromatography.
[U-14C] Oxalic acid (Amersham-Searle Corp) and oxalic acid (Sigma Chemical Co) were dissolved in 95% ethanol; chloroform was added to incipient cloudiness. The crystalline product was recrystallized from ethanol-chloroform; its uncorrected melting point,was 101-103'C (reported, 101-102°C); its specific activity was 24-7 ,uc per mMole.
[1,2-3H] Polyethylene glycol (New England Nuclear Corp) was used without further purification.
These isotopes were measured in a toluene-based mixture (Carter and Van Dyke, 1971) [3H]-polyethylene glycol, 0 5 mMolar; gas phase, 5% C02 in 02; pH, 7 5-7-7.
Oxalate, 0-2 mMolar, was chosen because this concentration may obtain in the human gastrointestinal tract. Man ingests about 1 mMole of oxalate daily (Zarembski and Hodgkinson, 1962) which may be dispersed in about 5 1 of luminal contents.
Sodium taurocholate was added at the expense of NaCl in the lest infusions.
CALCULATIONS
The amount of water absorbed by an intestinal segment was obtained from the differences between pump input and corrected intestinal output. The pump input was measured at the end of each experiment and was given by the slope of the regression line (Goldstein, 1964) between time and cumulative weights of six five-minute collection periods.
The intestinal output for each five-minute period had to be calculated from the weight of the intestinal effluent and its concentration of polyethylene glycol because the volume capacity of a living intestinal segment is inconstant.
For an ideal nonabsorbable marker, quantity infused into segment = quantity in effluent + quantity retained in segment Cin *Vin = Cout' Vout + Csegment *AV where C is the concentration of the marker, V is volume,zV is the change in capacity of the segment.
Csegment is assumed to be (Cin + Cout) + 2. The change in capacity of the segment is 2(Cin Vin -Cout Vout) Cin + Cout and the corrected output = weight of effluent + AV. There was no diminution in the absorption of water and oxalate when buffer was infused throughout an experiment. Taurocholate, 10 mMolar, had no effect on water absorption, which is consistent with a previous observation (Saunders, 1975 of both oxalate and water. Oxalate absorption and water absorption were linearly related in this experiment:y = 6 + 0-2x(r = 07;p < 005).
COLON (TABLES III AND IV)
The absorption of water and oxalate was constant when buffer was infused throughout an experiment. Mean oxalate absorption in control periods in the colon, 37 mumoles min-' g-1, was lower than in the ileum, 68 m,umoles min-' g-1, although net water transport during control periods was similar in both regions.
The results of infusing 10 mMolar taurocholate during test periods are given in table III. Taurocholate, 10 mMolar, depressed absorption of both oxalate and water. This depression was negated by calcium.
Oxalate absorption was linearly related to net water transport: y = -28 + 0.3 x (r = 0-6; p < 0.001) except when linoleic acid was present with 10 mMolar taurocholate. In this experiment, oxalate absorption was dissociated from net water transport (r = -0-1). Linoleic acid caused a greater depression of net water transport than did infusions containing only taurocholate (t = 3 68, p < 0-05), while it enhanced the absorption of oxalate. Calcium negated the inhibitory effort of linoleic acid on water transport and the stimulative effect of linoleic acid on oxalate absorption.
The results of infusing a lower concentration of taurocholate during control and test periods are given in table IV. Net water transport and oxalate absorption were unaffected by calcium or by linoleic acid with calcium; in these experiments oxalate absorption was linearly related to net water transport: y = -2 + 0-1 x (r = 0-5; p < 0-005). Linoleic acid without calcium depressed net water transport. but it did not inhibit oxalate absorption; in this experiment, oxalate absorption was dissociated from net water transport (r = 0 4; p < 0 1).
Discussion
This study indicates that regional differences in oxalate absorption exist in rat intestine. Because oxalate is passively absorbed by intestinal mucosa (Binder, 1974) , it was not surprising to find that manipulations which depressed net water transport in jejunum or in ileum also inhibited oxalate absorption. Disparate effects on water and on oxalate absorption were demonstrated in the colon, however.
Data from in-vitro and in-vivo experiments led us to expect the following results from infusing rat colon: Ca++ would inhibit oxalate absorption while added long-chain fatty acid would remove this inhibition by precipitating calcium (Binder, 1974) . Fatty acid without calcium, however, might depress net water transport (Ammon and Phillips, 1974; Bright-Asare and Binder, 1973) resulting in a concomitant depression of oxalate absorption. Actually, taurocholate seemed to prevent the precipitation of calcium oxalate; infusions of Ca++, and oxalate were optically clear, and oxalate absorption was uninhibited by Ca++. Linoleate did inhibit net water transport, but, paradoxically, it facilitated oxalate absorption from the colon. Ca++ negated these effects of long-chain fatty acid by, presumably, foiming insoluble calcium linoleate; linoleate infusions which contained Ca++ were opalescent.
Our data suggest that excessive luminal concentrations of bile salts and long-chain fatty acids may enhance oxalate absorption from a normal colon.
How relevant are these observations to understanding the hyperoxaluria of human intestinal disease? In the first place, the colon is responsible for a significant proportion of the normal intestinal absorption of oxalate in man (Earnest, 1974, personal communication) and in primates (Chadwick, Elias, Modha, and Dowling, 1973) , and it is necessary for the excessive absorption of oxalate in patients with enteiic hyperoxaluria. Patients who have had an extensive ileal resection and colectomy do not develop hyperoxaluria even with a diet high in oxalate (Earnest et al, 1974) . Enteric hyperoxaluria has not been described in ileostomy patients, who have a high incidence of renal calculi; their stones are of urate rather than of oxalate (Bennett and Jepson, 1966) .
In the second place, there appears to be a positive correlation between faecal fat and urinary oxalate (Earnest et al, 1974; Stauffer et al, 1974; Andersson and Jagenburg, 1974; McDonald et al, 1975) . Furthermore, increasing the amount of fat in an otherwise constant diet enhanced urinary oxalate excretion in patients with enteric hyperoxaluria (Earnest et al, 1974) .
In the third place, the human colon may be presented with high concentrations of bile salts and fatty acids in small intestinal disease. The small amount of bile salts in normal faeces is bound to solid material (Norman, 1964; Findlay, Eastwood, and Mitchell, 1973) . The concentration of bile salts can be 30 mMolar in the solid residue and 13 mMolar in the supernatant portion of faeces from patients with ileal resection or disease (Mitchell, Findlay, Prescott, Eastwood, and Horn, 1973; Hofmann and Poley, 1972) . Fatty acids in the aqueous phase would be a 2 mMolar if about 0-6 g of long-chain fatty acid could be solubilized by a litre of faecal water.
Finally, calcium, added to the diet, can decrease urinary oxalate excretion in patients with enteric hyperoxaluria (Earnest et al, 1974; Stauffer et al, 1974 ) although this therapy is not always successful (Chadwick, Modha, and Dowling, 1974) . Oxalate excretion is inversely related to the dietary intake of calcium in normal man (Zarembski and Hodgkinson, 1969) . The combination of low dietary calcium and high dietary oxalate produces the highest urinary oxalate excretion (Marshall, Cochran, and Hodgkinson, 1972) .
These combined observations suggest that small intestinal disease may lead to enhanced oxalate absorption from the colon by altering the composition of colonic contents. 
